<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03160547</url>
  </required_header>
  <id_info>
    <org_study_id>The EFFORT Trial</org_study_id>
    <nct_id>NCT03160547</nct_id>
  </id_info>
  <brief_title>The Effect of Higher Protein Dosing in Critically Ill Patients</brief_title>
  <acronym>EFFORT</acronym>
  <official_title>The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Registry-based Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Evaluation Research Unit at Kingston General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinical Evaluation Research Unit at Kingston General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator will investigate the effects of higher protein/amino acid dosing (≥2.2
      g/kg/d) vs lower protein/amino acid dosing (≤1.2 g/kg/d) on clinical outcomes in
      nutritionally high risk ill patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The EFFORT Study is a multi-center, pragmatic, volunteer-driven, registry-based, randomized,
      clinical trial of 4000 nutritionally high-risk critically ill patients in the intensive care
      unit (ICU). We anticipate over 100 sites participating internationally, with each site
      enrolling a minimum of 30 patients. Patients will be randomized to 1 of 2 treatment groups: a
      lower prescription (≤1.2 g/kg/d) or a higher prescription (≥2.2 g/kg/d) of protein. Other
      than the protein amount the patient is randomized to, the remainder of care provided to
      randomized patient will be at the discretion of ICU providers.

      In both groups, targets will be achieved through any combination of enteral nutrition (high
      protein content in high group if available), protein supplements, and parenteral nutrition or
      amino acids only (as clinically available). The only difference between the 2 groups is the
      protein targets that are set. Similar efforts should be used in both groups to achieve at
      least 80% of these targets. The remainder of care provided to eligible patients will be at
      the discretion of ICU providers.

      The investigator has posed two research questions:

      Primary Research Question:

      In critically ill patients with nutrition 'risk factors', what is the effect of prescribing a
      higher dose (≥2.2 grams/kg/day) of protein/amino acid administration compared to a low group
      prescribed ≤1.2 gram/kg/day on 60 day mortality?

      Secondary Research Question:

      In critically ill patients with nutrition 'risk factors', what is the effect of prescribing a
      higher dose (≥2.2 grams/kg/day) of protein/amino acid administration compared to patients
      prescribed ≤1.2 gram/kg/day on time to discharge alive from hospital?

      The proposed hypothesis:

      Compared to receiving lower dose of protein/amino acids, the administration of a higher dose
      of protein/amino acids (a consequence of having a higher prescription) to nutritionally
      high-risk critically ill patients will be associated with improved survival and a quicker
      rate of recovery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 17, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>60-day mortality</measure>
    <time_frame>60 day</time_frame>
    <description>Mortality 60 days post randomization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to discharge alive from hospital</measure>
    <time_frame>60 day</time_frame>
    <description>This is a composite of mortality and length of stay, evaluated up to 60 days post randomization</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Nutritional Adequacy</measure>
    <time_frame>60 day</time_frame>
    <description>To be evaluated up to 60 days post randomization</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>60 day</time_frame>
    <description>To be evaluated up to 60 days post randomization</description>
  </other_outcome>
  <other_outcome>
    <measure>Readmission to ICU and Hospital</measure>
    <time_frame>60 day</time_frame>
    <description>To be evaluated up to 60 days post randomization</description>
  </other_outcome>
  <other_outcome>
    <measure>Duration of Mechanical Ventilation</measure>
    <time_frame>60 day</time_frame>
    <description>To be evaluated up to 60 days post randomization</description>
  </other_outcome>
  <other_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>60 day</time_frame>
    <description>To be evaluated up to 60 days post randomization</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>60 day</time_frame>
    <description>To be evaluated up to 60 days post randomization</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Critical Illness</condition>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>Lower Protein/Amino Acid Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a lower protein/amino acid dose (≤1.2 g/kg/d)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Higher Protein/Amino Acid Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a higher protein/amino acid dose (≥2.2 g/kg/d).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lower Protein/Amino Acid Group</intervention_name>
    <description>Protein targets will be set using pre-ICU dry actual weight. For patients with BMI &gt;30, ideal body weight based on a BMI of 25 will be used. We will endorse the guidelines for energy targets set forth by ASPEN/SCCM, especially as it pertains to the obese patient.</description>
    <arm_group_label>Lower Protein/Amino Acid Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Higher Protein/Amino Acid Group</intervention_name>
    <description>Protein targets will be set using pre-ICU dry actual weight. For patients with BMI &gt;30, ideal body weight based on a BMI of 25 will be used. We will endorse the guidelines for energy targets set forth by ASPEN/SCCM, especially as it pertains to the obese patient.</description>
    <arm_group_label>Higher Protein/Amino Acid Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ≥18 years old

          2. Nutritionally 'high-risk' (meeting one of the below criteria)

               1. Low (≤25) or High BMI (≥35)

               2. Moderate to severe malnutrition (as defined by local assessments). We will
                  document the means by which sites are making this determination and capture the
                  elements of the assessment (history of weight loss, history of reduced oral
                  intake, etc.).

               3. Frailty (Clinical Frailty Scale 5 or more from proxy)

               4. Sarcopenia- (SARC-F score of 4 or more from proxy)

               5. From point of screening, projected duration of mechanical ventilation &gt;4 days

          3. Requiring mechanical ventilation with actual or expected total duration of mechanical
             ventilation &gt;48 hours

        Exclusion Criteria:

          1. &gt;96 continuous hours of mechanical ventilation before screening

          2. Expected death or withdrawal of life-sustaining treatments within 7 days from
             screening

          3. Pregnant

          4. The responsible clinician feels that the patient either needs low or high protein

          5. Patient requires parenteral nutrition only and site does not have products to reach
             the high protein dose group.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daren K Heyland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Evaluation Research Unit</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daren K Heyland, MD</last_name>
    <phone>1 403 915-5573</phone>
    <email>dkh2@queensu.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Janet Overvelde</last_name>
    <phone>613-549-6666</phone>
    <phone_ext>6241</phone_ext>
    <email>Janet.Overvelde@kingstonhsc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>OU Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Allen, MD</last_name>
      <email>karen-allen@ouhsc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Leah Hoffman, RD</last_name>
      <email>Leah-hoffman@ouhsc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania - MICU</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlene Compher, PhD</last_name>
      <phone>215-898-3619</phone>
      <email>compherc@nursing.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Charlene Compher, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Rice, MD</last_name>
      <email>todd.rice@Vanderbilt.Edu</email>
    </contact>
    <investigator>
      <last_name>Todd Rice, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Britanico de Buenos Aires</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1280AEB CABA</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Chapela, MD</last_name>
      <email>spchapela@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Facundo Gutierrez, MD</last_name>
      <email>facundo_gutierrez@yahoo.com.ar</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Grey Bruce Health Services</name>
      <address>
        <city>Owen Sound</city>
        <state>Ontario</state>
        <zip>N4K 6M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Mailhot-Hall, RD</last_name>
      <email>lmailhothall@gbhs.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Andrew Kuhl, MD</last_name>
      <email>akuhl@gbhs.on.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital San Javier</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44670</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Miranda, MD</last_name>
      <email>ackerman1976@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Francisco Barbosa, MD</last_name>
      <email>efebeka_@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Canada</country>
    <country>Mexico</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hoffer LJ, Bistrian BR. Appropriate protein provision in critical illness: a systematic and narrative review. Am J Clin Nutr. 2012 Sep;96(3):591-600. doi: 10.3945/ajcn.111.032078. Epub 2012 Jul 18. Review.</citation>
    <PMID>22811443</PMID>
  </reference>
  <reference>
    <citation>Heyland DK, Cahill N, Day AG. Optimal amount of calories for critically ill patients: depends on how you slice the cake! Crit Care Med. 2011 Dec;39(12):2619-26. doi: 10.1097/CCM.0b013e318226641d.</citation>
    <PMID>21705881</PMID>
  </reference>
  <reference>
    <citation>Jolly SS, Cairns JA, Yusuf S, Meeks B, Pogue J, Rokoss MJ, Kedev S, Thabane L, Stankovic G, Moreno R, Gershlick A, Chowdhary S, Lavi S, Niemelä K, Steg PG, Bernat I, Xu Y, Cantor WJ, Overgaard CB, Naber CK, Cheema AN, Welsh RC, Bertrand OF, Avezum A, Bhindi R, Pancholy S, Rao SV, Natarajan MK, ten Berg JM, Shestakovska O, Gao P, Widimsky P, Džavík V; TOTAL Investigators. Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med. 2015 Apr 9;372(15):1389-98. doi: 10.1056/NEJMoa1415098. Epub 2015 Mar 16.</citation>
    <PMID>25853743</PMID>
  </reference>
  <reference>
    <citation>Fan E, Dowdy DW, Colantuoni E, Mendez-Tellez PA, Sevransky JE, Shanholtz C, Himmelfarb CR, Desai SV, Ciesla N, Herridge MS, Pronovost PJ, Needham DM. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med. 2014 Apr;42(4):849-59. doi: 10.1097/CCM.0000000000000040.</citation>
    <PMID>24247473</PMID>
  </reference>
  <reference>
    <citation>De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphaël JC, Outin H, Bastuji-Garin S; Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002 Dec 11;288(22):2859-67.</citation>
    <PMID>12472328</PMID>
  </reference>
  <reference>
    <citation>Hermans G, Van Mechelen H, Clerckx B, Vanhullebusch T, Mesotten D, Wilmer A, Casaer MP, Meersseman P, Debaveye Y, Van Cromphaut S, Wouters PJ, Gosselink R, Van den Berghe G. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014 Aug 15;190(4):410-20. doi: 10.1164/rccm.201312-2257OC.</citation>
    <PMID>24825371</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2017</study_first_submitted>
  <study_first_submitted_qc>May 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2017</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Evaluation Research Unit at Kingston General Hospital</investigator_affiliation>
    <investigator_full_name>Daren K. Heyland</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

